20:13 EDT Cathie Wood’s ARK Investment bought 412K shares of Recursion Pharmaceuticals
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX:
- ESPN goes dark on DirecTV, Harris to oppose Nippon-U.S. Steel deal: Morning Buzz
- Recursion Pharmaceuticals price target lowered to $6 from $8 at Jefferies
- Recursion Pharmaceuticals Proposes Strategic Exscientia Merger
- Recursion: Phase 2 Data of REC-994 for CCM met primary endpoint for safety
- Recursion Pharmaceuticals call volume above normal and directionally bullish